Safety and Efficacy of an Oral Therapeutic APX3330 from ZETA-1 Phase 2 Trial in Patients with Diabetic Retinopathy
APX3330
Presented at the Macula Society 46th Annual Meeting
Filter by:
Presented at the Macula Society 46th Annual Meeting
Bascom Palmer Eye Institute
Presented at American Society of Cataract and Refractive Surgery 2022
Presented at American Academy of Ophthalmology 2021
Presented at American Academy of Ophthalmology 2021
Presented at American Society of Cataract and Refractive Surgery 2021
Presented at American Society of Cataract and Refractive Surgery 2021
Indiana University School of Medicine
Indiana University School of Medicine